|
Originally published In Press as doi:10.1074/jbc.M108839200 on October 30, 2001
J. Biol. Chem., Vol. 277, Issue 4, 2763-2772, January 25, 2002
Molecular Characterization of the Starfish Inositol
1,4,5-Trisphosphate Receptor and Its Role during Oocyte
Maturation and Fertilization*
Hirohide
Iwasaki §¶,
Kazuyoshi
Chiba ,
Tsuyoshi
Uchiyama §,
Fumio
Yoshikawa**,
Fumiko
Suzuki ,
Masako
Ikeda ,
Teiichi
Furuichi**, and
Katsuhiko
Mikoshiba §
From the Laboratory for Developmental Neurobiology,
Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, the § Division of Molecular Neurobiology, Institute
of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku,
Tokyo 108-8039, Japan, the Department of Biology, Ochanomizu
University, 2-1-1 Ootsuka, Bunkyo-ku, Tokyo 112-8610, Japan,
** Laboratory for Molecular Neurogenesis, Brain Science,
Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, and the
 Department of Biosciences, Graduate School
of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan
Received for publication, September 13, 2001, and in revised form, October 25, 2001
 |
ABSTRACT |
The release of calcium ions
(Ca2+) from their intracellular stores is essential
for the fertilization of oocytes of various species. The calcium pools
can be induced to release Ca2+ via two main types of
calcium channel receptor: the inositol 1,4,5-trisphosphate receptor
(IP3R) and the ryanodine receptor. Starfish oocytes have
often been used to study intracellular calcium mobilization during
oocyte maturation and fertilization, but how the intracellular calcium
channels contribute to intracellular calcium mobilization has never
been understood fully, because these molecules have not been identified
and no specific inhibitors of these channels have ever been found. In
this study, we utilized a novel IP3R antagonist, the
"IP3 sponge," to investigate the role of
IP3 during fertilization of the starfish oocyte. The
IP3 sponge strongly and specifically competed with
endogenous IP3R for binding to IP3. By
injecting IP3 sponge into starfish oocyte, the increase in
intracellular calcium and formation of the fertilization envelope were
both dramatically blocked, although oocyte maturation was not blocked.
To investigate the role of IP3R in the starfish oocyte more
precisely, we cloned IP3R from the ovary of starfish, and
the predicted amino acid sequence indicated that the starfish IP3R has 58-68% identity to mammalian IP3R
types 1, 2, and 3. We then raised antibodies that recognize starfish
IP3R, and use of the antibodies to perform immunoblot
analysis revealed that the level of expression of IP3R
remained unchanged throughout oocyte maturation. An immunocytochemical
study, however, revealed that the distribution of starfish
IP3R changes during oocyte maturation.
 |
INTRODUCTION |
A dramatic transient release of Ca2+ from internal
stores has been demonstrated during fertilization (1-3). This rise in
Ca2+ is essential to the stimulation of many subsequent
events in egg activation, including exocytosis of cortical granules
(which establish polyspermy blocks), and reentry of the egg into the meiotic cell cycle. Ca2+ can be released from internal
stores via two main types of calcium channel receptors: (i) the
inositol 1,4,5-trisphosphate receptor (IP3R),1 which is
responsive to the second messenger, inositol 1,4,5-trisphosphate (IP3), and (ii) the ryanodine receptor (RyR), which is
insensitive to IP3 but can be stimulated by calcium or
other agents, including ryanodine, caffeine, and the naturally
occurring metabolite cyclic adenosine diphosphate-ribose. Nicotinic
acid adenine dinucleotide phosphate is also known to release
Ca2+ from internal stores in sea urchin eggs (4, 5) and
starfish eggs (6), but the molecular mechanism is still unknown.
Several observations suggest that IP3 mediates
Ca2+ release during fertilization: (i) phosphatidylinositol
lipid turnover and IP3 levels increase rapidly during
fertilization (7-11), (ii) IP3 injection of unfertilized
eggs and IP3 application to endoplasmic reticulum isolated
from eggs causes calcium release (12-18), (iii) injection of
phospholipase C- Src homology 2 domain into oocyte inhibits
Ca2+ release during fertilization by inhibiting the
generation of IP3 (19), and (iv) injection of oocytes with
heparin, a nonspecific competitive inhibitor of IP3R,
causes abnormal fertilization-induced calcium dynamics in a
dose-dependent fashion (20-24). However, the effects of
heparin are difficult to interpret because of its lack of specificity.
In some studies, heparin has been found to reduce ryanodine-induced
(25) and cyclic adenosine diphosphate-ribose-induced (26)
Ca2+ release, and heparin has been reported to inhibit
cortical granule exocytosis even after a Ca2+ rise of near
normal amplitude has occurred (27). In addition, frog eggs injected
with ~300 µg/ml heparin have been reported to often exhibit
splotchy pigmentation characteristic of unhealthy eggs (23).
Monoclonal antibody 18A10, which binds to the carboxyl terminus of
IP3R and specifically inhibits IP3-induced
Ca2+ release (IICR), provides a more specific approach. In
hamster eggs, complete inhibition was obtained with more than 100 µg/ml IP3R antibody 18A10, whereas 200~800 µg/ml
heparin only partially inhibited Ca2+ release during
fertilization (28). However, 18A10 does not always cross-react with
IP3Rs from other species, because it was raised against
mouse IP3R1 (mIP3R1) and its epitope is not
conserved well among all the reported IP3Rs of different
species and types. In fact, we have confirmed by immunoblot analysis
that 18A10 does not recognize starfish IP3R (data not shown).
In this study, we used a novel IP3R antagonist, the
"IP3 sponge," which we recently developed to identify
the physiological role of IP3R in starfish oocytes
(29).2 IP3R is
composed of three major functional domains: an N-terminal ligand-binding domain, a modulatory domain in the middle, and a
transmembrane domain near the C terminus (30, 31). In our previous
study, we found that amino acids (aa) 226-578 of mIP3R1 are the core region for IP3 binding and that the
bacterially expressed aa 224-604 has markedly higher binding affinity
than aa 1-604 (29).2 Although the IP3 binding
core region of aa 224-604 was not efficiently expressed as a soluble
active form, this problem was overcome by N-terminal fusion of aa
224-604 with glutathione S-transferase. The resulting
fusion protein was called "G224." G224 showed high IP3
binding activity, approximately ~1000 times greater than that of
endogenous IP3R in mouse cerebellar microsomes (see Fig. 1 and "Experimental Procedures").2 G224 strongly,
specifically, and dose-dependently competed with endogenous
IP3R for binding to IP3. We therefore decided
to call G224 the "IP3 sponge," because it blocked IICR
by absorbing IP3.
Fully grown immature starfish oocytes have a large nucleus called the
"germinal vesicle" (GV) and are arrested at the first meiotic
prophase. The prophase arrest is released in response to a starfish
maturation-inducing hormone, 1-methyladenine (1-MA), which acts on the
oocyte surface (32). At 20 °C, germinal vesicle breakdown (GVBD;
nuclear disassembly), a sign of resumption of meiosis reinitiation,
occurs ~20 min after application of 1-MA. After GVBD, oocytes acquire
increased sensitivity to sperm and IP3, which results in a
release of calcium from intracellular stores and a rise in
intracellular free calcium (16). We expressed IP3 sponge in
Escherichia coli and injected it into immature starfish oocytes to investigate the role of IP3R during oocyte
maturation and fertilization. Moreover, to identify the role of
IP3R in starfish more precisely, we cloned the starfish
IP3R cDNA and used the predicted amino acid sequence of
starfish IP3R to raise antibodies that recognize the
receptor and to investigate the level of expression of IP3R
during oocyte maturation. We also examined immunocytochemistry to
investigate changes in localization of the IP3R in oocytes during maturation.
 |
EXPERIMENTAL PROCEDURES |
Preparation of Gametes--
Starfish Asterina
pectinifera were collected on the Pacific coast of Honshu
and kept in a laboratory aquarium supplied with circulating sea water
at 17 °C. In this paper we use the term "oocyte" to refer to
fully grown immature oocytes at meiotic prophase and "egg" to refer
to the maturing oocytes after GVBD stimulated with 1-MA to resume
meiosis. 1-MA was obtained from Sigma and used at 1-2
µM. Isolated ovaries were incubated in ice-cold
calcium-free sea water to remove follicle cells, and the oocytes
released were washed twice in ice-cold calcium-free sea water and
stored in artificial sea water at 20 °C. Sperm were collected from
an excised testis and stored on ice without dilution. Except as noted,
the sperm were diluted with artificial sea water (106
times volume of the testis extract) before addition to the chamber containing the eggs.
Microinjection of IP3 Sponge into Immature
Oocytes--
Preparation of the IP3 sponge was described
elsewhere (29).2 Briefly, to express N-terminal fused
proteins of residues 224-604 of mIP3R1 with the
glutathione S-transferase gene, the cDNA that encodes aa
224-604 of mIP3R1 was amplified by PCR by using pET-1-604 (29) as a template and subcloned into pGEX-2T (Amersham Biosciences, Inc.). Site-directed mutagenesis of K508A was introduced by two-step PCR, as described elsewhere (33). Expression of recombinant proteins in
E. coli was carried out by the low temperature method (33),
and purification of these proteins with glutathione-Sepharose CL4B
beads was done according to the manufacturer's method (Amersham Biosciences). The purified proteins were then applied to a PD-10 column
containing Sephadex G-25 M (Amersham Biosciences)
preequilibrated with elution buffer (88 mM NaCl, 1 mM KCl, 10 mM Hepes-KOH, pH 7.2). Protein
concentration was determined using a kit (Bio-Rad) with bovine serum
albumin as the standard and adjusted to a concentration of 2 mg/ml with
elution buffer. The volume injected was 5% of the oocyte volume
(oocyte volume was ~3 nl). The concentrations of
IP3 sponge, GST-m30, and GST in cytoplasm were ~1.5, 1.5, and 3 µM, respectively. The injection was made with a
micropipette with an oil-filled constriction connected to a
syringe (34, 35). The oocytes were held between two coverslips
separated by two pieces of double-stick tape during the microinjection
and the observation period (36). IP3 was dissolved in 100 mM potassium aspartate, 10 mM Hepes, pH 7.0, at
a series of concentrations ranging from 10 7 to
10 4 M. The injected volume was 1% of the
cell volume.
Calcium Measurement--
The fluorescence from an oocyte
injected with 1 mM Fura2-dextran was collected with a ×20,
0.5 N.A. objective and focused onto a photomultiplier (Nikon, P1)
mounted on an inverted fluorescence microscope; excitation filters at
360 ± 10 and 380 ± 10 nm, dichroic beam splitter at 400 nm,
and long pass emission filters at 420 and 450 nm were used. Fura-2
fluorescence was observed at 20 °C by exciting Fura-2 at 380 nm.
Fura-2 fluorescence induced by excitation at 360 nm was observed both
at the beginning and at the end of the observation period to calibrate
bleaching of the dye.
Molecular Cloning of Starfish IP3R--
Total RNA
from starfish ovary was purified on an RNeasy column (Qiagen-GmbH,
Hilden, Germany). Reverse transcription was performed using SuperScript
II (Invitrogen). The degenerate oligonucleotide primers used were as
follows: 5'-1
(5'-GTT(T/C)CAIGC(T/C)GA(A/G)CA(A/G)GA(A/G)AA(A/G)TT-3') and
3'-1a (5'-G(T/C)TTIGC(A/G/T)AT(A/G)TA(T/C)TC(T/C)TG(A/G)TT(T/C)TT-3') plus 3'-1b
(5'-G(T/C)TTIGC(A/G/T)AT(A/G)TG(T/C)TC(T/C)TG(A/G)TT(T/C)TT-3'); 5'-2
(5'-GAA(A/G)AA(T/C)GTITA(T/C)ACIGA(A/G)AT(T/C/A)AA(A/G)TG-3') and 3'-2
(5'-G(A/G)TA(A/G/T)AT(T/C)TC(T/C)TTCA(T/C)TCIAC(T/C)TCIGT(A/G)TC-3'); 5'-3
(5'-GGA(A/G)TA(T/C)TG(T/C)CA(A/G)GGICCITG(T/C)CA(T/C)GA(A/G)AA(T/C)CA-3' and 3'-3
(5'-G(A/G)TCIGC(A/G)AAIGT(A/G)TC(A/G/T)AT(A/G/T)ATIACICC(A/G)AA-3'), as
described in the legend to Fig. 6A.
PCR was performed using AmpliTaq DNA polymerase (PerkinElmer Life
Sciences). The thermocycler was programmed for 94 °C denaturation for 2 min followed by 40 cycles of 94 °C denaturation for 45 s, 50 °C annealing for 45 s, and 72 °C extension for 1 min. The
final cycle was followed by an additional extension at 72 °C for 6 min. These products were subcloned into the T/A vector pCR2.1
(Invitrogen, Carlsbad, CA) and sequenced with the dideoxy method.
Other pairs of primers used to clone the residual parts of
IP3R were 5'-0.5 (5'-CCACCAAA(A/G)AA(A/G)TT(C/T)AGAGA-3')
and 3'-0.5 (5'-CCTCAGGAAGATGTAGCTCT-3'), 5'-1.5
(5'-GCATTCTCAGGCTGTCACAG-3') and 3'-1.5
(5'-TCCAGTGGTAGCAGGGAGTG-3'), and 5'-2.5 (5'-GGAGGATGCCTACATCAACT-3') and 3'-2.5 (5'-TTGATGTCGTTCAGTATGAG-3'), as described in the legend to
Fig. 6A.
PCR was performed using Platinum Pfx DNA polymerase (Invitrogen). The
thermocycler was programmed for 94 °C denaturation for 2 min
followed by 40 cycles of 94 °C denaturation for 15 s, 50 °C
annealing for 30 s, and 68 °C extension for 3 min. The final cycle was followed by an additional extension at 68 °C for 7 min. These products were subcloned into the EcoRV site of
pBlueScript KS ( ) (Toyobo, Osaka, Japan).
5'- and 3'-untranslated region were isolated with the
5'-RACE System for Amplification of cDNA Ends, version 2.0 (Invitrogen) and the 3'-RACE System for Amplification of cDNA Ends
(Invitrogen), respectively. The gene-specific
primers used were as follows: 5'-RACE gene-specific primer-1,
5'-CTCTTGCTCAGCATGGAAGA-3'; 5'-RACE gene-specific primer-2,
5'-TCTTCTCTAGCAAGGCTGGT-3'; 3'-RACE gene-specific primer-1,
5'-TACCAACACCTGGGTGCATA-3'; 3'-RACE gene-specific primer-2, and
5'-TGCTCTGACAGCCTGAGAAT-3', as described in the legend to Fig.
6A.
Antibody Production--
Rabbit polyclonal antibody was raised
against a synthetic oligopeptide corresponding to amino acid residues
595-604 of mIP3R1 (LAEDTITALLHNNRK) (37). The peptide was
coupled via an additional N-terminal cysteine to keyhole limpet
hemocyanin with the cross-linking reagent
m-maleimidobenzoyl-N-hydroxysuccinimide ester.
Mice (C3HB6, female, 6 weeks) were used to raise monoclonal antibody
against a synthetic peptide based on the sequence of amino acid
residues 2684-2698 of starfish IP3R (INLLSSPSIPQMGGP). The
peptide was coupled via an additional N-terminal cysteine to mouse
albumin with the cross-linking agent
m-maleimidobenzoyl-N-hydroxysuccinimide ester.
Splenocytes from immunized mice were fused to PAI (BALB/c mouse-derived
myeloma) to produce a hybridoma. The hybridoma cells were
screened by enzyme-linked immunosorbent assay, and positive cells were
diluted to a single clone. Antibody classes were identified with a
mouse monoclonal antibody isotyping kit RPN29 (Amersham Biosciences).
SDS-PAGE and Immunoblot Analysis--
A 30-fold volume of SDS
sample buffer was added to pellets of defolliculated immature oocytes
and mature eggs, and the specimens were heated for 15 min at 55 °C.
Samples of the specimens were subjected to 5% SDS-PAGE according to
Laemmli's method (38). After SDS-PAGE, the separated proteins in the
gel were electrophoretically transferred to Immobilon-P (Millipore
Corp., Bedford, MA). The membrane was incubated in 5% skim milk (Snow
Brand, Sapporo, Japan) dissolved in PBS-Tween 20 (0.1%) for 2 h,
and then incubated with monoclonal antibody (culture supernatant of
hybridoma) overnight at 4 °C. After washing the membrane with
PBS-Tween 20, it was exposed to the secondary antibody (1:1000;
horseradish peroxidase-conjugated anti-mouse immunoglobulin from
donkey; Amersham Biosciences), and the labeled bands were identified on
x-ray film using enhanced chemiluminescence (ECL; Amersham
Biosciences). The density of each band was analyzed by LAS-1000
(Fujifilm, Tokyo, Japan).
Immunocytochemistry and DAPI Staining--
Oocytes were treated
with 0.02% Pronase (Kaken Seiyaku, Tokyo, Japan) at 20 °C in
artificial sea water and washed several times with ice-cold
Ca2+-free artificial sea water to remove the
vitelline membrane. The oocytes were then fixed with 4%
paraformaldehyde for 1 h at room temperature and permeabilized
with PBS-Triton X-100 (0.1%). Sperm nuclei were stained by staining
the inseminated eggs with 0.1 µg/ml DAPI for 30 min at room
temperature and washed twice with PBS. The starfish IP3R
was immunostained by using the polyclonal antibody (1:300 dilution)
described above as the primary antibody subsequently after blocking
with 2% of normal goat serum (Vector Laboratories, Burlingame, CA).
Rhodamine-conjugated anti-rabbit IgG (from goat) (Cappel, Organon
Teknika Corp., West Chester, PA) was used as the secondary antibody.
After washing with PBS, the specimens were mounted in Vectorshield
(Vector Laboratories, Burlingame, CA). Specimens were observed by
confocal microscopy, TCS NT (Leica Microsystems Heidelberg,
Mannheim, Germany).
 |
RESULTS |
IP3 Sponge Inhibits IP3-induced
Ca2+ Release--
The "IP3 sponge" is a
truncated form of IP3R that consists of the ligand binding
domain fused to GST (Fig. 1). The
IP3 sponge has been found to exhibit high IP3
binding affinity, approximately ~1000 times higher than that of
endogenous IP3R in mouse cerebellar microsomes (Fig.
1),2 and thus it blocked IP3-induced
Ca2+ release (IICR) by absorbing IP3. GST-m30
is a mutant of IP3 sponge in which Lys-508 is substituted
for Ala, and it displays low affinity for IP3,
approximately ~0.25 times lower than that of endogenous IP3R in mouse cerebellar microsomes (Fig. 1).2
Accordingly, GST and GST-m30 can be used as negative controls of
IP3 sponge.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Construction of IP3 sponge and
its binding affinity to IP3. At the top is a schematic
representation of the N-terminal region of mouse IP3R1,
with the IP3 binding core (aa 226-578) indicated by a solid
line. G224 (the IP3 sponge) is a protein in
which GST has been fused to the truncated mutant of mIP3R1
(aa 224-604). GST-m30 is a K508A mutant of G224. GST was also used as
a negative control. The binding affinity to IP3 was
calculated by Scatchard plot analysis of inhibition of specific
[3H]IP3 (9.6 nM) binding to
GST-fused IP3 binding proteins by cold IP3
(28).
|
|
First, we examined whether IP3 sponge inhibited IICR in
starfish oocyte by injecting various concentrations of IP3
into oocyte (Fig. 2). After injecting
more than 10 6 M IP3
(10 8 M IP3 in cytoplasm, after
1% injection) into mature eggs that have been injected with 3 µM GST (equal to 0.1 mg/ml in cytoplasm), a
Ca2+ peak was observed, and a fertilization envelope was
formed. By contrast, after injecting less than 10 6
M IP3, no fertilization envelope formation or
Ca2+ peak was observed in eggs that had been injected with
1.5 µM IP3 sponge (equal to 0.1 mg/ml in
cytoplasm). However, after injecting more than 10 4
M IP3 (10 6 M
IP3 in cytoplasm, after 1% injection), both a calcium rise and a fertilization envelope were observed in eggs injected with IP3 sponge. At 10 5 M
IP3, an increase in Ca2+ was not observed in
most cases, but in some cases, a Ca2+ peak was observed
after a delay (about 5 min), or, in some cases, the baseline increased
gradually and reached a plateau within 5 min (data not shown). In these
cases, a fertilization envelope was observed after measurement of
intracellular Ca2+. Thus, injection of a high dose of
IP3 overcame the inhibitory effects of IP3
sponge, suggesting that the effect of IP3 sponge was
specific.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of microinjection of oocytes with
IP3 on calcium release in response to IP3.
A, calcium release in response to IP3 injection
in eggs injected with GST or IP3 sponge. Immature oocytes
were injected with GST or IP3 sponge, and
[Ca2+]i was measured at 1 h after 1-MA
stimulation. The IP3 concentrations indicated were those in
the pipettes from which injections of 1% of the cell volume were made.
The traces show the fluorescence ratio
(F360/F380) emitted by
Fura-2 dextran. a-d, GST-injected eggs. Eggs
a, b, and c formed fertilization
envelopes; egg d did not. e-g,
IP3 sponge-injected eggs. Egg e
formed a fertilization envelope. B, calcium release by eggs
in response to IP3 injection. The x axis
indicates the IP3 concentrations in the pipettes, from
which injections of 1% of the cell volume were made. The y
axis indicates the
(F360/F380)peak (F360/F380)baseline
at each concentration of IP3. Data are the means ± S.E. of eggs (n = 6) injected with GST ( ) or
IP3 sponge ( ) (*, p < 0.1;
**p < 0.05; t test).
|
|
Role of IP3R during Oocyte Maturation and
Fertilization--
Next, we used IP3 sponge to investigate
the physiological roles of IP3R during starfish oocyte
maturation and fertilization.
When immature oocytes injected with 1.5 µM
IP3 sponge were treated with 1-2 µM 1-MA to
induce maturation, 85% (90 of 106) of oocytes underwent GVBD, similar
to results with control oocytes injected with 3 µM GST
(94%; 138 of 147) or 1.5 µM (equal to 0.1 mg/ml in
cytoplasm) GST-m30 (96%; 67 of 70) did (Figs.
3 and 4). Thus, the IP3 sponge did not inhibit 1-MA-induced oocyte
maturation.

View larger version (116K):
[in this window]
[in a new window]
|
Fig. 3.
Microinjection of oocytes with
IP3 sponge prevents formation of fertilization
envelope. Oocytes injected with GST (A and
C) or IP3 sponge (B and D)
were treated with 1-MA and then inseminated. A and
B, bright field images. Both oocytes injected with GST
(A) and IP3 sponge (B) underwent
GVBD. By contrast, oocytes injected with IP3 sponge lacked
the ability to develop a fertilization envelope (B),
although GST-injected eggs developed a normal fertilization envelope.
C and D, the nuclei of the eggs stained with
DAPI. A single sperm nucleus entered the GST-injected eggs
(C), whereas several sperm nuclei entered IP3
sponge-injected eggs (D). Scale bar,
100 µm.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Microinjection of oocytes with
IP3 sponge prevents formation of fertilization envelope:
Statistical analysis. Oocytes were injected with IP3
sponge, treated with 1-MA, 2 µM, and inseminated. GST and
GST-m30 were utilized as negative controls. The y axis shows
the percentages of oocytes that underwent normal GVBD in response to 2 µM 1-MA (left) or the percentages of eggs that
developed a normal fertilization envelope when inseminated
(right). The number of oocytes that underwent normal GVBD
was calculated 1 h after stimulation with 1-MA. The number of eggs
that developed a normal fertilization envelope was counted 15 min after
insemination. Each bar shows the results for oocytes
injected with GST (open bar), GST-m30
(dotted bar), or IP3 sponge
(filled bar).
|
|
After GVBD, these eggs injected with recombinant proteins were
inseminated with sperm diluted to 10 6. IP3
sponge did not inhibit sperm penetration, since DAPI staining of these
eggs showed that sperm nuclei had entered into the cells preinjected
with IP3 sponge (Fig. 3D). Polar body extrusion
was also unaffected by the IP3 sponge (Fig. 3B).
However, the formation of a fertilization envelope was clearly
inhibited in eggs injected with IP3 sponge (13%; 12 of
90), whereas those injected with control proteins developed a
fertilization envelope (GST: 94%, 129 of 138; GST-m30: 90%, 60/67)
(Figs. 3 and 4).
Since the intracellular calcium rise during fertilization is known to
be involved in the formation of the fertilization envelope, the
IP3 sponge probably inhibited IICR. Indeed, when the
concentration of intracellular calcium ion was measured with Fura-2
dextran, the transient increase in Ca2+ during
fertilization was greatly reduced of the eggs preinjected with
IP3 sponge (Fig.
5B), whereas GST had no such
inhibitory effect (Fig. 5A). When treated with sperm diluted
to 10 4, a delay of the Ca2+ peak or a gradual
base-line elevation was observed in the oocyte that had been injected
with IP3 sponge. These results may have occurred because
the IP3 sponge in oocytes was saturated with IP3, thereby diminishing the inhibitory effect of
IP3 sponge.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
Microinjection of oocyte with IP3
sponge inhibits elevation of intracellular calcium levels during
fertilization. Oocytes were injected with GST (A) or
IP3 sponge (B) and treated with 1-MA to induce
maturation. After GVBD, the eggs were inseminated. The intracellular
calcium level was monitored by using Fura-2 dextran. The x
axis indicates the time course, and the y axis indicates the
fluorescence ratio
(F360/F380). The data
shown represent the results of typical experiments repeated at least
five times. The arrows indicate the time when sperm was
added to the chamber. A, in the eggs injected with GST, the
intracellular calcium level rose normally during fertilization.
B, in the oocyte-injected IP3 sponge, the
intracellular calcium elevation during fertilization was
inhibited.
|
|
Primary Structure of Starfish IP3R--
To investigate
the roles of IP3R in starfish oocyte further, we cloned the
IP3R from starfish ovary by RT-PCR. Degenerate oligonucleotides encoding the sequence conserved among all of the
reported IP3Rs of different species and types were used as the primers, and they are shown in Fig.
6A. Although
we used degenerate primers encoding the sequence conserved among all of
the reported IP3Rs of different species and types, the
sequences of the PCR products were identical to the sequence shown in
Fig. 6B, and there were no products with different
sequences. The 9374-nucleotide sequence of the cloned starfish
IP3R contained a single open reading frame of 8094 bp
encoding a protein of 2698 amino acids (Fig. 6B), and the
calculated molecular mass of starfish IP3R was 308 kDa.


View larger version (107K):
[in this window]
[in a new window]
|
Fig. 6.
Primary structure of starfish
IP3R. A, primers used for the amplification
of starfish IP3R by RT-PCR. LBD, ligand
binding domain; MD, modulatory domain; CHD,
channel domain. B, predicted amino acid sequence (in
single-letter code) of starfish IP3R (top) and
alignment with hIP3R1 (SI+, SII , SIII+) is shown.
C, phylogenic tree of IP3Rs generated using the
ClustalW program. D, Kyte-Doolittle hydrophobicity profile
of starfish IP3R generated with a window size of 10 amino
acids.
|
|
Sequence alignment of starfish IP3R with known full-length
human IP3R sequences showed that starfish IP3R
most closely resembled IP3R1. The amino acid sequence of
starfish IP3R was 68% identical to human IP3R1
(hIP3R1) (39), 62% identical to hIP3R2 (40), and 58% identical to hIP3R3 (40). When compared with the
IP3R of other species, starfish IP3R was found
to be 68% identical to mIP3R1 (41), 67% identical to
Xenopus IP3R (42), 58% identical to
Drosophila IP3R (43), and 41% identical to
C. elegans IP3R (44) (Fig. 6C).
The structure of IP3R can be divided into three
functionally different domains: an NH2-terminal
ligand-binding domain, a long modulatory domain presumed to span the
cytoplasm, and a transmembrane domain near the C terminus.
Ligand Binding Domain--
The N-terminal amino acid residues (aa
1-604 of mIP3R1) reported as the IP3-binding
domain within the large cytoplasmic portion of the IP3Rs
show significant sequence similarities with the different species and
receptor types. This region of starfish IP3R (aa 1-593) also displays high similarity to human IP3R (75% to type
1, 70% to type 2, 67% to type 3). It is especially noteworthy that
all three basic amino acid residues (Arg-265, Lys-508, and Arg-511) in
mIP3R1 that are known to have a crucial role in
IP3 binding are conserved in starfish IP3R
residues (Arg-265, Lys-497, and Arg-500 of starfish IP3R)
(33). An alternative splicing region in the ligand binding domain, the
SI region, has been reported in mouse, rat, and human IP3R1
(45). However, all of the reported IP3Rs except for the
ones from these animals lack this region, suggesting that
IP3Rs are generally spliced at SI. Starfish
IP3R, shown in Fig. 6, also lacks this region.
Modulatory Domain--
The modulatory domain of starfish
IP3R (aa 594-2224) shows 67% similarity to
hIP3R1, 60% to hIP3R2, and 54% to
hIP3R3, and it contains several sites that are thought to
modulate IP3 function in channel opening, including
cAMP-dependent protein kinase (PKA), cGMP-dependent protein kinase, and ATP. A PKA
phosphorylation site is present at positions 1833-1836. This site can
also be phosphorylated by cGMP-dependent protein kinase.
Both kinases are known to modulate the function of IP3R
(46-52). ATP is known to significantly potentiate in IP3Rs
from cerebellum (53-55). Two consensus Gly-rich sequences
(GXGXXG) for nucleotide binding were found in the
mIP3R1 (aa 1773-1778 (or 1775-1780)) and aa 2016-2021), but only one of them, corresponding to aa 2016-2021 in the
mIP3R1, was conserved in the sequence of starfish
IP3R (aa 1958-1964 in starfish IP3R). Several
consensus sites of protein kinase C have also been found throughout the
sequence of starfish IP3R. Thus, starfish IP3R
can be regulated by these factors described above.
Putative Channel Domain--
The putative channel domain of
starfish IP3R (aa 2225-2698) showed 59% similarity to
hIP3R1, 58% to hIP3R2, and 55% to
hIP3R3. Hydropathy profiles (Fig. 6D) suggested
that starfish IP3R contains six potential membrane-spanning
segments, M1-M6, near the C terminus. These six hydrophobic regions
were thought to form part of the channel region (56). In the putative
large luminal loop regions, the putative pore between M5 and M6,
hIP3R1 and IP3R2 have two potential
N-glycosylation sites, whereas hIP3R3 has only
one. However, neither of these N-glycosylation sites has
been conserved in starfish IP3R. The similarities between
sequences in this region described above were lower than in other parts
of the IP3R, because the similarity between the regions
between M5 and M6 was extremely low. There was absolutely no sequence
similarity between the 10 C-terminal amino acids of starfish
IP3R and mIP3R1, and as a result, a monoclonal
antibody, 18A10, which recognizes the C terminus of mIP3R1,
does not cross-react with starfish IP3R.
Expression of IP3R during Oocyte Maturation--
From
quantitative injections of IP3, it was found that 100-fold
less IP3 was sufficient to release the same amount of
Ca2+ in mature starfish eggs than in immature oocytes (16).
However, the mechanism of increase in sensitivity to IP3
has remained elusive. To investigate whether the sensitization of
starfish oocytes to IP3 is due to the elevation of the
expression level of IP3R, we examined the expression level
of IP3R by immunoblot analysis.
We raised a polyclonal antibody against a synthetic oligopeptide having
the highly conserved peptide sequence of the IP3 binding domain. This region was also conserved in starfish IP3R.
Immunoblot analysis using the antibody yielded a single band with a
smaller molecular weight than that of mIP3R1 (Fig.
7A). We also raised a
monoclonal antibody against the 15-amino acid C-terminal sequence of
starfish IP3R, and it detected a single band having exactly the same molecular size as obtained with the polyclonal antibody (Fig.
7A). The monoclonal antibody did not recognize
mIP3R1 (data not shown). These findings are consistent with
the fact that there is no similarity between mIP3R1 and
starfish IP3R in this region. Preabsorption of antibody
with antigen diminished the band, suggesting that this antibody
specifically recognized the starfish IP3R.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 7.
Immunoblot analysis of starfish
IP3R during oocyte maturation. A,
immunoblot of starfish IP3R. C, the microsomal
fraction of mouse cerebellum; S, starfish oocytes. The
microsomal fraction of mouse cerebellum was used as the positive
control (lane 1). The IP3R was probed
with polyclonal antibody that recognizes the ligand binding domain of
IP3R. The size of the starfish IP3R was smaller
than that of the mouse one (lane 2). A band of
the same size was detected by using a monoclonal antibody that
recognizes the C terminus of starfish IP3R (lane
3). B, the level of expression of
IP3R during oocyte maturation was detected by using
polyclonal antibody (a) and monoclonal antibody
(b). The number above each
lane indicates the time after 1-MA treatment when each
sample was collected and treated with SDS-PAGE sample buffer. In this
experiment, GVBD occurred 15 min after the application of 1-MA.
C, densitometric analysis showing the relative intensity of
the band corresponding to starfish IP3R. The intensities
are plotted as multiples of intensity relative to immature oocytes
before stimulation with 1-MA. The density of each band was analyzed by
using LAS-1000.
|
|
Next we used these antibodies to perform immunoblot analysis as a means
of determining the level of expression of IP3R during oocyte maturation. Oocytes were collected at various times after 1-MA
treatment and treated with SDS-PAGE sample buffer. Samples loaded in
each lane were prepared so that they contained approximately the same
numbers of oocytes. Fig. 7B shows that the level of
expression of IP3R during oocyte maturation. Densitometric
analysis confirmed that the level of expression of IP3R did
not change significantly during oocyte maturation (Fig.
7C).
Localization of IP3R during Oocyte Maturation--
We
then investigated the distribution of IP3R during oocyte
maturation. Immunocytochemistry was performed with the polyclonal antibody against the IP3 binding domain, and signals were
detected by confocal microscopy. In immature oocytes, IP3R
distributed throughout the cytoplasm but not in the GV (Fig.
8A). Localization of the
IP3R was then examined at various stages of oocyte
maturation. When the GV was disintegrating 20 min after 1-MA treatment,
a large patch of signal was observed at the site where the GV had been
(Fig. 8B). After GVBD (40 min after 1-MA treatment), the signal patch dispersed, and signals were evenly distributed throughout the egg (Fig. 8C). These changes of localization were
observed using more than 100 eggs from several animals. The signals
were diminished by preincubation with primary antibody to the synthetic peptide used as antigen (Fig. 8D), suggesting that the
signals were specific to the IP3R.

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 8.
Immunocytochemistry of starfish
IP3R during oocyte maturation. Starfish
IP3R was immunocytochemically characterized by confocal
microscopy. Polyclonal antibody was used as the primary antibody, and
rhodamine-conjugated IgG (anti-rabbit IgG) was used as the secondary
antibody. A, an immature oocyte. Signals are distributed
throughout the cytoplasm and absent in the GV. B, an oocyte
undergoing GVBD (20 min after application of 1-MA). The signals are
concentrated in the area where a GV had been present in the immature
oocyte. C, a mature egg. Signals are redistributed
throughout the cytoplasm. D, no signals were observed
when primary antibody was preincubated with antigen. Scale
bar, 100 µm.
|
|
 |
DISCUSSION |
Microinjection of starfish eggs with IP3 sponge did
not inhibit either sperm penetration during fertilization or polar body extrusion, but it did block the increase in
[Ca2+]i and formation of the fertilization
envelope. Since IP3 sponge exhibited high affinity for
IP3, the inhibition of the calcium rise is probably due to
the IP3 sponge absorbing IP3. Indeed, more than
10 times as much IP3 was required to achieve the same
calcium release in a IP3 sponge-injected egg as in a control egg. These results clearly indicate that IICR is the major contributor to the increase in [Ca2+]i during the
fertilization of starfish eggs. Oocyte maturation, however, was not
inhibited by the injection of IP3 sponge, indicating that
IICR is not essential for meiosis reinitiation, although a transient
Ca2+ increase has been reported to occur in response to
1-MA treatment (57, 58).
The contribution of IICR during fertilization of hamster eggs has also
been clearly demonstrated by using 18A10, the specific antibody against
the IP3R1 (28). However, the antibody did not recognize
starfish IP3R, and it cannot inhibit IICR completely when
the cells of interest express multiple types of IP3R.
IP3 sponge can be applied to cells of various species,
including those whose IP3R has not yet been identified and
to the cells in which multiple types of IP3R are expressed.
GST or GST-m30 can be used as a negative control for IP3
sponge. Thus, the IP3 sponge may open the way to
understanding the mechanisms of calcium dynamics in various cells from
different species.
We cloned IP3R from starfish ovary by RT-PCR. Of all of the
types of human IP3R known, starfish IP3R was
closest to IP3R1. Although the degenerate primers used in
this study were designed within the regions that are highly conserved
among all types of IP3R, all of the clones amplified by
RT-PCR were identical. These findings suggest that the IP3R
shown in Fig. 6 is dominantly expressed in starfish ovary, and starfish
may have only one type of IP3R, the same as
Drosophila. None of the products had sequences similar to
those of IP3R2 or IP3R3. The PCR product shown
in Fig. 6, however, cannot be classified simply as IP3R1,
because some of the residues in the sequence of the starfish
IP3R are not conserved in IP3R1 but are
conserved in hIP3R2 or IP3R3. Therefore, the
sequence of the starfish IP3R should be interpreted as a
mixture of the three types of mammalian IP3R rather than as
IP3R1.
The sensitivity of starfish oocytes to IP3 is known to
increase during maturation (16). The results presented here show that
the level of expression of IP3R remained unchanged
throughout starfish oocyte maturation. Therefore, the sensitization of
IICR during starfish oocyte maturation was not due to an increase in level of expression of IP3R. A similar change has been seen
during mouse (59) and Xenopus (60) oocyte maturation, but it
has been reported that the number of IP3R increases during
oocyte maturation in these species. However, the increases in
IP3R number reported in these studies are too small (1.2×
in Xenopus oocyte (60) and 1.8× in mouse oocytes (59)) to
account for the dramatic change of sensitization of oocyte to
IP3 during oocyte maturation. Therefore, it may be that in
all of these species, modulation of the IP3 receptor is
more important than receptor number in explaining the IP3
sensitivity change. Seen from this point of view, the starfish is a
particularly valuable "model system" to study a general phenomenon.
One of the possibilities is that starfish IP3R is modulated
during maturation. Indeed, there are many consensus sequences of
various kinases or substances, including PKA,
cGMP-dependent protein kinase, protein kinase C, and ATP.
Interestingly, cAMP decreases during starfish oocyte maturation (61),
and there is a putative PKA phosphorylation site in the sequence of
starfish IP3R. Thus, PKA-dependent
phosphorylation of IP3R may modulate the function of
IP3R in immature oocytes. However, the effect of PKA on
IP3R is controversial. By the study using purified
mIP3R1 reconstituted into lipid vesicles, PKA
phosphorylation enhances the function of IP3R1 (46). There
are several lines of evidence that phosphorylation by PKA increases
IICR in platelets (47), hepatocytes (48), and cerebellar membranes
(49). By contrast, Supattapone et al. (50) and Quinton and
Dean (51) reported that phosphorylation by PKA of cerebellar membranes
or platelet membranes substantially reduced the potency of
IP3 in releasing Ca2+. Therefore, the real
nature of IP3R regulation by PKA has remained elusive in
starfish oocyte. It is also possible that other kinases such as protein
kinase C (62) and protein kinase C-related kinase 2 (63) phosphorylate
starfish IP3R. Such modifications may be responsible for
the sensitization of IP3R during oocyte maturation. Because
the starfish oocyte undergoes a rapid and large change in sensitivity
to IICR in response to application of a hormone, it provides an
excellent system for future studies of IP3 receptor modulation.
In immature oocytes, IP3R signals were
distributed throughout the cytoplasm, but none were detected in the GV
(Fig. 8A). When the GV was disintegrating after 1-MA
treatment, the IP3Rs were concentrated at the site where
the GV had been located (Fig. 8B), whereas after GVBD, they
were evenly distributed throughout the egg (Fig. 8C). A
structural change in the endoplasmic reticulum, which presumably
contains an IP3-sensitive calcium store, has been observed
during starfish oocyte maturation and fertilization by using DiI (64)
and a green fluorescence protein targeted to the lumen of the
endoplasmic reticulum (65, 66). In addition, translocation of
IP3Rs from the perinuclear region to the cortex has been
reported in studies in mouse (59) and Xenopus (60) oocyte.
These structural changes in the endoplasmic reticulum or in the
distribution of IP3Rs may contribute to the sensitization of IICR during oocyte maturation.
 |
ACKNOWLEDGEMENTS |
We thank Drs. T. Inoue, T. Michikawa, M. Hattori (University of Tokyo), A. Mizutani (RIKEN), and J. Hirota
(Rockefeller University) for valuable discussions, Dr. M. Hino-Yamamoto
(RIKEN) for cloning starfish IP3R, Dr. M. Hoshi (Keio
University) for the monoclonal antibody, and M. Iwai (University
of Tokyo) for excellent technical support.
 |
FOOTNOTES |
*
This work was supported by grants from the Ministry of
Education, Science, Sports, and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB071372.
¶
To whom correspondence should be addressed. Tel.:
81-48-467-9745; Fax: 81-48-467-9744; E-mail:
hiwasaki@ims.u-tokyo.ac.jp.
Published, JBC Papers in Press, October 30, 2001, DOI 10.1074/jbc.M108839200
2
T. Uchiyama, F. Yoshikawa, A. Hishida, T. Furuichi, and K. Mikoshiba, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
IP3R, inositol 1,4,5-trisphosphate receptor;
IP3, inositol
1,4,5-trisphosphate;
IICR, IP3-induced Ca2+
release;
GV, germinal vesicle;
GVBD, germinal vesicle breakdown;
1-MA, 1-methyladenine;
GST, glutathione S-transferase;
RyR, ryanodine receptor;
mIP3R1, mouse IP3R1;
PBS, phosphate-buffered saline;
DAPI, 4',6-diamidino-2-phenylindole;
hIP3R1, -2, and -3, human IP3R1, -2, and -3, respectively;
PKA, cAMP-dependent protein kinase;
RT, reverse transcription;
RACE, rapid amplification of cDNA ends;
aa, amino acids.
 |
REFERENCES |
| 1.
|
Berridge, M. J.
(1993)
Nature
361,
315-325
|
| 2.
|
Miyazaki, S.
(1995)
Curr. Opin. Cell Biol.
7,
190-196
|
| 3.
|
Stricker, S. A.
(1999)
Dev. Biol.
211,
157-176
|
| 4.
|
Galione, A.,
McDougall, A.,
Busa, W. B.,
Willmott, N.,
Gillot, I.,
and Whitaker, M.
(1993)
Science
261,
348-352
|
| 5.
|
Lee, H. C.,
Aarhus, R.,
and Walseth, T. F.
(1993)
Science
261,
352-355
|
| 6.
|
Santella, L.,
Kyozuka, K.,
Genazzani, A. A., De,
Riso, L.,
and Carafoli, E.
(2000)
J. Biol. Chem.
275,
8301-8306
|
| 7.
|
Turner, P. R.,
Sheetz, M. P.,
and Jaffe, L. A.
(1984)
Nature
310,
414-415
|
| 8.
|
Kamel, L. C.,
Bailey, J.,
Schoenbaum, L.,
and Kinsey, W.
(1985)
Lipids
20,
350-356
|
| 9.
|
Ciapa, B.,
and Whitaker, M.
(1986)
FEBS Lett.
195,
347-351
|
| 10.
|
Ciapa, B.,
Borg, B.,
and Whitaker, M.
(1992)
Development
115,
187-195
|
| 11.
|
Stith, B. J.,
Goalstone, M.,
Silva, S.,
and Jaynes, C.
(1993)
Mol. Biol. Cell
4,
435-443
|
| 12.
|
Whitaker, M.,
and Irvine, R. F.
(1984)
Nature
312,
636-639
|
| 13.
|
Swann, K.,
and Whitaker, M.
(1986)
J. Cell Biol.
103,
2333-2342
|
| 14.
|
Terasaki, M.,
and Sardet, C.
(1991)
J. Cell Biol.
115,
1031-1037
|
| 15.
|
Picard, A.,
Giraud, F., Le,
Bouffant, F.,
Sladeczek, F., Le,
Peuch, C.,
and Doree, M.
(1985)
FEBS Lett.
182,
446-450
|
| 16.
|
Chiba, K.,
Kado, R. T.,
and Jaffe, L. A.
(1990)
Dev. Biol.
140,
300-306
|
| 17.
|
Busa, W. B.,
Ferguson, J. E.,
Joseph, S. K.,
Williamson, J. R.,
and Nuccitelli, R.
(1985)
J. Cell Biol.
101,
677-682
|
| 18.
|
Miyazaki, S.
(1988)
J. Cell Biol.
106,
345-353
|
| 19.
|
Carroll, D. J.,
Ramarao, C. S.,
Mehlmann, L. M.,
Roche, S.,
Terasaki, M.,
and Jaffe, L. A.
(1997)
J. Cell Biol.
138,
1303-1311
|
| 20.
|
Rakow, T. L.,
and Shen, S. S.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
9285-9289
|
| 21.
|
Stricker, S. A.
(1995)
Dev. Biol.
170,
496-518
|
| 22.
|
Santella, L., De,
Riso, L.,
Gragnaniello, G.,
and Kyozuka, K.
(1999)
Exp. Cell Res.
248,
567-574
|
| 23.
|
Nucitelli, R.,
Yim, D. L.,
and Smart, T.
(1993)
Dev. Biol.
158,
200-212
|
| 24.
|
Kline, J. T.,
and Kline, D.
(1994)
Biol. Reprod.
50,
193-203
|
| 25.
|
Sardet, C.,
Speksnijder, J.,
Terasaki, M.,
and Chang, P.
(1992)
Development
115,
221-237
|
| 26.
|
Shen, S. S.,
and Buck, W. R.
(1993)
Dev. Biol.
157,
157-169
|
| 27.
|
Buck, W. R.,
Rakow, T. L.,
and Shen, S. S.
(1992)
Exp. Cell Res.
202,
59-66
|
| 28.
|
Miyazaki, S.,
Yuzaki, M.,
Nakada, K.,
Shirakawa, H.,
Nakanishi, S.,
Nakade, S.,
and Mikoshiba, K.
(1992)
Science
257,
251-255
|
| 29.
|
Yoshikawa, F.,
Uchiyama, T.,
Iwasaki, H.,
Tomomori-Satoh, C.,
Tanaka, T.,
Furuichi, T.,
and Mikoshiba, K.
(1999a)
Biochem. Biophys. Res. Commun.
257,
792-797
|
| 30.
|
Mignery, G. A.,
and Südhof, T. S.
(1990)
EMBO J.
9,
3893-3898
|
| 31.
|
Miyawaki, A.,
Furuichi, T.,
Ryo, Y.,
Yoshikawa, S.,
Nakagawa, T.,
Saitoh, T.,
and Mikoshiba, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4911-4915
|
| 32.
|
Kanatani, H.,
Shirai, H.,
Nakanishi, K.,
and Kurosawa, T.
(1969)
Nature
221,
273-274
|
| 33.
|
Yoshikawa, F.,
Morita, M.,
Monkawa, T.,
Michikawa, T.,
Furuichi, T.,
and Mikoshiba, K.
(1996)
J. Biol. Chem.
271,
18227-18284
|
| 34.
|
Kiehart, D. P.
(1982)
Methods Cell Biol.
25,
13-31
|
| 35.
|
Kishimoto, T.
(1988)
Methods Cell Biol.
27,
379-394
|
| 36.
|
Chiba, K.,
Tadenuma, H.,
Matsumoto, M.,
Takahashi, K.,
Katada, T.,
and Hoshi, M.
(1992)
Eur. J. Biochem.
207,
833-838
|
| 37.
|
Yoshikawa, F.,
Iwasaki, H.,
Michikawa, T.,
Furuichi, T.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
328-334
|
| 38.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 39.
|
Yamada, N.,
Makino, Y.,
Clark, R. A.,
Pearson, D. W.,
Mattei, M. G.,
Guenet, G. L.,
Ohama, E.,
Fujino, I.,
Miyawaki, A.,
Furuichi, T.,
and Mikoshiba, K.
(1994)
Biochem. J.
302,
781-790
|
| 40.
|
Yamamoto-Hino, M.,
Sugiyama, T.,
Hikichi, K.,
Mattei, M. G,
Hasegawa, K.,
Sekine, S.,
Sakurada, K.,
Miyawaki, A.,
Furuichi, T.,
Hasegawa, M.,
and Mikoshiba, K.
(1994)
Receptors Channels
2,
9-22
|
| 41.
|
Furuichi, T.,
Yoshikawa, S.,
Miyawaki, A.,
Wada, K.,
Maeda, N.,
and Mikoshiba, K.
(1989)
Nature
342,
32-38
|
| 42.
|
Kume, S.,
Muto, A.,
Aruga, J.,
Nakagawa, T.,
Michikawa, T.,
Furuichi, T.,
Nakade, S.,
Okano, H.,
and Mikoshiba, K.
(1993)
Cell
73,
555-570
|
| 43.
|
Yoshikawa, S.,
Tanimura, T.,
Miyawaki, A.,
Nakamura, M.,
Yuzaki, M.,
Furuichi, T.,
and Mikoshiba, K.
(1992)
J. Biol. Chem.
267,
16613-16619
|
| 44.
|
Baylis, H. A.,
Furuichi, T.,
Yoshikawa, F.,
Mikoshiba, K.,
and Sattelle, D. B.
(1999)
J. Mol. Biol.
294,
467-476
|
| 45.
|
Nakagawa, T.,
Okano, H.,
Furuichi, T.,
Aruga, J.,
and Mikoshiba, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
6244-6248
|
| 46.
|
Nakade, S.,
Rhee, S. K.,
Hamanaka, H.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
6735-6742
|
| 47.
|
Enouf, J.,
Graud, F.,
Bredoux, R.,
Bordeau, N.,
and Toledano-Levy, S.
(1987)
Biochim. Biophys. Acta
928,
76-82
|
| 48.
|
Burgess, G. M.,
Bird, G. St. J.,
Obie, J. F.,
and Putney, J. W., Jr.
(1991)
J. Biol. Chem.
266,
4772-4781
|
| 49.
|
Volpe, P.,
and Alderson-Lang, B. H.
(1990)
Am. J. Physiol.
258,
1086-1091
|
| 50.
|
Supattapone, S.,
Danoff, S. K.,
Theibert, A.,
Joseph, S. K.,
Steiner, J.,
and Snyder, S. H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8747-8750
|
| 51.
|
Quinton, T. M.,
and Dean, W. L.
(1992)
Biochem. Biophys. Res. Commun.
184,
893-899
|
| 52.
|
Koga, T.,
Yoshida, Y.,
Cai, J.-Q.,
Islam, M. O.,
and Imai, S.
(1994)
J. Biol. Chem.
269,
11640-11647
|
| 53.
|
Ehlich, B. E.,
and Watras, J.
(1988)
Nature
336,
583-586
|
| 54.
|
Ferris, C. D.,
Huganir, R. L.,
and Snyder, S. H.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2232-2235
|
| 55.
|
Maeda, N.,
Kawasaki, T.,
Nakade, S.,
Yokota, N.,
Taniguchi, T.,
Kasai, M.,
and Mikoshiba, K.
(1991)
J. Biol. Chem.
266,
1109-1116
|
| 56.
|
Michikawa, T.,
Hamanaka, H.,
Otsu, H.,
Yamamoto, A.,
Miyawaki, A.,
Furuichi, T.,
Tashiro, Y.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
9184-9189
|
| 57.
|
Santella, L.,
and Kyozuka, K.
(1994)
Biochem. Biophys. Res. Commun.
203,
674-680
|
| 58.
|
Witchell, H. J.,
and Steinhardt, R. A.
(1990)
Dev. Biol.
141,
393-398
|
| 59.
|
Mehlmann, L. M.,
Mikoshiba, K.,
and Kline, D.
(1996)
Dev. Biol.
180,
489-498
|
| 60.
|
Terasaki, M.,
Runft, L. L.,
and Hand, A. R.
(2001)
Mol. Biol. Cell
12,
1103-1116
|
| 61.
|
Meijer, L.,
and Zarutskie, P.
(1987)
Dev. Biol.
121,
306-315
|
| 62.
|
Xu, Z.,
Dholakia, J. N.,
and Hille, M. B.
(1993)
Dev Genet.
14,
424-439
|
| 63.
|
Stapleton, G.,
Nguyen, C. P.,
Lease, K. A.,
and Hille, M. B.
(1998)
Dev. Biol.
193,
36-46
|
| 64.
|
Jaffe, L. A.,
and Terasaki, M.
(1994)
Dev. Biol.
164,
579-587
|
| 65.
|
Terasaki, M.,
Jaffe, L. A.,
Hunnicutt, G. R.,
and Hammer, J. A., III
(1996)
Dev. Biol.
179,
320-328
|
| 66.
|
Terasaki, M.
(1994)
J. Cell Sci.
107,
1797-1805
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Whitaker
Calcium signalling in early embryos
Phil Trans R Soc B,
April 12, 2008;
363(1495):
1401 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev,
April 1, 2007;
87(2):
593 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lee, E. Vermassen, S.-Y. Yoon, V. Vanderheyden, J. Ito, D. Alfandari, H. De Smedt, J. B. Parys, and R. A. Fissore
Phosphorylation of IP3R1 and the regulation of [Ca2+]i responses at fertilization: a role for the MAP kinase pathway
Development,
November 1, 2006;
133(21):
4355 - 4365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsu-ura, T. Michikawa, T. Inoue, A. Miyawaki, M. Yoshida, and K. Mikoshiba
Cytosolic inositol 1,4,5-trisphosphate dynamics during intracellular calcium oscillations in living cells
J. Cell Biol.,
June 5, 2006;
173(5):
755 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Whitaker
Calcium at Fertilization and in Early Development
Physiol Rev,
January 1, 2006;
86(1):
25 - 88.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Iwai, Y. Tateishi, M. Hattori, A. Mizutani, T. Nakamura, A. Futatsugi, T. Inoue, T. Furuichi, T. Michikawa, and K. Mikoshiba
Molecular Cloning of Mouse Type 2 and Type 3 Inositol 1,4,5-Trisphosphate Receptors and Identification of a Novel Type 2 Receptor Splice Variant
J. Biol. Chem.,
March 18, 2005;
280(11):
10305 - 10317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lim, E. Ercolano, K. Kyozuka, G. A. Nusco, F. Moccia, K. Lange, and L. Santella
The M-phase-promoting Factor Modulates the Sensitivity of the Ca2+ Stores to Inositol 1,4,5-Trisphosphate via the Actin Cytoskeleton
J. Biol. Chem.,
October 24, 2003;
278(43):
42505 - 42514.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|